Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH)

✍ Scribed by Salim Daya; Matts Wikland; Kaylen M. Silverberg; Selina Blatz; Gerard Duru; Ariel Beresniak

• Book ID: 119420652
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 41 KB
• Volume: 80
• Category: Article
• ISSN: 1556-5653
• DOI: 10.1016/s0015-0282(03)01241-x